Elotuzumab
AbbVie,BMS
['mmsm', 'krd ']
#asco23 #mmsm dosing schema: 6 cycles (c) of krd or e-krd, (chemomobilisation for asct after c3), single (tandem, if &lt;cr/high risk ndmm) hdt/asct, followed by 4 consolidation c (krd/e-krd) and r or er maintenance
Assistant professor @UAMSMyeloma. Alumni heme/onc @bcmhouston, clinical research/biostat @UMich.Focus on plasma cell disorders & health disparities